KHP Capital’s iShares Biotechnology ETF IBB Stock Holding History

KHP Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$177K	Hold	1,450	–	–	0.11%	71
2018 Q2	$159K	Buy	1,450 +550	+61%	+$58.8K	0.1%	70
2018 Q1	$96K	Buy	+900	New	+$99.8K	0.07%	82

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

KHP Capital's IBB Position: Q3 2018 in Review

KHP Capital held its iShares Biotechnology ETF (IBB) position steady in Q3 2018 at 1,450 shares worth $177K. The position accounts for 0.11% of the portfolio, ranked #71.

KHP Capital first reported a position in IBB in Q1 2018 and has held it in 3 quarters since. 631 funds tracked by Wall St. Rank hold IBB as of Q3 2018.

KHP Capital held 1,450 shares of iShares Biotechnology ETF worth $177K as of Q3 2018.
KHP Capital left its iShares Biotechnology ETF share count unchanged in Q3 2018.
iShares Biotechnology ETF made up 0.11% of KHP Capital's portfolio in Q3 2018, its #71 holding.
KHP Capital first reported a position in iShares Biotechnology ETF in Q1 2018 and has held it in 3 quarters since.
631 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2018.

Based on KHP Capital's 13F filing for Q3 2018, filed 8 Nov 2018.